PROM1 and pancreatic neoplasm: Hermann et al. used CD133 as a marker to isolate pancreatic cancer cells with a significantly higher tumorigenic potential, and CD133+CXCR4+ cancer cells with a significantly higher metastatic potential in addition [10].